In vitro and in vivo experiments verified that SHMT2 knockdown promotes GC progression through various pathways such as regulating the stability of HIF1α, affecting the downstream VEGF and STAT3 pathways, and maintaining redox homeostasis in GC cells under hypoxic conditions (124). The gene discussed is VEGFA; the disease is gastric cancer.